Soda and Fatty Liver Disease: Risks and Advice

Soda and fatty liver disease are increasingly linked in both research and clinical practice. Regular consumption of sugary fizzy drinks delivers a significant fructose load to the liver, which can drive fat accumulation over time, contributing to non-alcoholic fatty liver disease (NAFLD), now also termed metabolic dysfunction-associated steatotic liver disease (MASLD). Affecting an estimated one in three UK adults to some degree, NAFLD/MASLD is largely driven by diet and lifestyle. This article explains the mechanisms behind the link, what early signs to watch for, which drinks to limit, and what NHS and NICE guidance recommends for protecting and recovering liver health.

Can drinking fizzy drinks really cause fatty liver disease?

Regular sugary fizzy drink consumption is associated with increased NAFLD/MASLD risk because the liver converts excess fructose from these drinks into fat, though diet, genetics and physical activity also contribute.

Regular consumption of sugary fizzy drinks is associated with an increased risk of developing non-alcoholic fatty liver disease (NAFLD), also increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), though fizzy drinks alone are rarely the sole cause. NAFLD/MASLD is a condition in which excess fat accumulates in liver cells in people who drink little or no alcohol. It affects an estimated one in three adults in the UK to some degree, according to the British Liver Trust.^[1][2]

The liver plays a central role in processing sugars absorbed from the gut, and when it is overwhelmed by large quantities of fructose, a sugar found in many carbonated soft drinks, it begins converting that excess into fat. In the UK, most commercially produced fizzy drinks are sweetened with sucrose (table sugar, which is roughly half fructose) or glucose-fructose syrup, rather than the high-fructose corn syrup more commonly used in the United States. The metabolic effect on the liver is broadly similar, because all of these sweeteners deliver a significant fructose load.

The link between fizzy drink consumption and liver fat is supported by observational research, though it is important to note that diet, physical activity, genetics and overall calorie intake all contribute to NAFLD/MASLD risk. Observational studies cannot prove causation, and confounding factors, such as a generally poor diet or low physical activity, may partly explain the association. Drinking sugary soft drinks regularly tends to sit alongside other dietary patterns, such as high intake of processed foods and refined carbohydrates, that collectively raise liver fat. No single food or drink causes NAFLD in isolation, but fizzy drinks are a meaningful and modifiable part of the picture.

For people already at risk of metabolic conditions, including those with obesity, type 2 diabetes or insulin resistance, the impact of regular sugary drink consumption on the liver may be more pronounced. Understanding the specific mechanisms by which these drinks affect liver metabolism is an important step in making informed dietary choices.

How sugary and diet fizzy drinks affect fat build-up in the liver

Sugary drinks drive liver fat accumulation via fructose, which the liver converts to triglycerides through de novo lipogenesis; diet drinks do not deliver fructose and are not linked to fatty liver by UK guidance.

Sugary fizzy drinks drive liver fat accumulation primarily through their fructose content, which the liver metabolises differently from glucose. Unlike glucose, which is used by cells throughout the body, fructose is processed almost exclusively in the liver. When fructose arrives in large quantities, as it does after drinking a standard can of cola or a sweetened fizzy drink, the liver converts the surplus into triglycerides through a process called de novo lipogenesis. Over time, repeated exposure leads to fat deposits building up within liver cells, a hallmark of NAFLD/MASLD.

In the UK, the main sweeteners used in commercially produced fizzy drinks are sucrose and glucose-fructose syrup. Sucrose is approximately half fructose; glucose-fructose syrup also delivers a substantial fructose fraction. A standard 330 ml can of cola typically contains around 35 g of sugar, much of which is fructose. Consuming several cans per day delivers a substantial fructose load to the liver on a daily basis.

The picture with diet fizzy drinks is less straightforward. Diet drinks contain low or no-calorie sweeteners (LNCS) rather than sugar, so they do not deliver fructose directly. The UK Scientific Advisory Committee on Nutrition (SACN) has concluded that LNCS are safe within acceptable daily intake levels and can help people reduce their overall sugar consumption.^[6][7] Some research suggests that LNCS may influence gut bacteria and insulin signalling, but the evidence in humans remains limited and mixed, and no UK guidance identifies diet fizzy drinks as a direct cause of fatty liver disease. Diet drinks are generally considered a lower-risk alternative to sugary versions for liver fat specifically, but water and unsweetened drinks remain the preferred choice according to NHS dietary advice.

What are the early signs of fatty liver disease to watch for?

Early fatty liver disease most commonly causes no symptoms and is often found incidentally; when symptoms occur, they include persistent fatigue, upper right abdominal discomfort and mild nausea.

Early fatty liver disease most commonly produces no symptoms at all, which is why it is often discovered incidentally during blood tests or an ultrasound scan carried out for another reason. This absence of obvious warning signs makes it particularly important for people with known risk factors, such as obesity, type 2 diabetes, high cholesterol or a diet high in sugar and processed foods, to discuss liver health with their GP proactively.

When symptoms do occur in the earlier stages, they tend to be vague and easy to attribute to other causes. These may include:

• Persistent fatigue or low energy that does not improve with rest

• A dull ache or discomfort in the upper right side of the abdomen, where the liver sits

• Mild nausea or a general sense of feeling unwell

Note that weight gain and central adiposity are risk factors for NAFLD/MASLD rather than symptoms of the condition itself.

Blood tests may show mildly elevated liver enzymes, such as alanine aminotransferase (ALT) or aspartate aminotransferase (AST), though normal liver enzymes do not rule out fatty liver disease. If a GP suspects NAFLD/MASLD, the NHS and NICE (guideline NG49) recommend a structured assessment: an ultrasound scan to detect steatosis, followed by calculation of a FIB-4 score to assess the likelihood of significant fibrosis.^[9][10] In adults with an indeterminate or high FIB-4 result, an enhanced liver fibrosis (ELF) test is recommended before considering transient elastography (FibroScan).^[9][11] People with evidence of advanced fibrosis or cirrhosis should be referred to a liver specialist.

Seek same-day or emergency medical attention if you develop any of the following, as these may indicate advanced liver disease: yellowing of the skin or whites of the eyes (jaundice), swelling of the abdomen (ascites), confusion or unusual drowsiness, vomiting blood or passing black tarry stools, or severe itching accompanied by jaundice. These symptoms require urgent assessment and should not be managed by self-referral to a pharmacy.

Early identification of NAFLD/MASLD allows lifestyle changes to be made before the condition progresses to more advanced stages such as non-alcoholic steatohepatitis (NASH, also called metabolic dysfunction-associated steatohepatitis or MASH) or cirrhosis.

Which drinks should you cut back on to protect your liver?

Standard sugary fizzy drinks, fruit juices, energy drinks and alcohol are the most significant dietary contributors to liver fat and should be limited, with water as the preferred alternative.

To protect liver health, the drinks most worth reducing are those with a high sugar content, particularly those sweetened with sucrose, glucose-fructose syrup or similar sugars. The following categories are worth limiting:

• Standard fizzy drinks (cola, lemonade, fruit-flavoured sodas): typically high in sugar and fructose, these are among the most significant dietary contributors to liver fat when consumed regularly

• Fruit juices and smoothies: even 100% fruit juice contains concentrated fructose without the fibre of whole fruit. UK dietary guidance recommends limiting fruit juice and smoothies to a combined total of 150 ml per day, as larger quantities contribute to free sugar intake in a way that can affect liver fat over time^[4][5]

• Energy drinks: often high in both sugar and caffeine; their high sugar content is the primary concern for liver health, and UK guidance recommends that children and young people avoid them

• Sweetened iced teas and flavoured waters: these can contain surprisingly high sugar levels despite appearing healthier

• Alcohol: even in the absence of alcoholic fatty liver disease, alcohol adds to the liver's metabolic burden and can worsen NAFLD/MASLD

Water is the most liver-friendly drink and should be the primary choice throughout the day. Unsweetened tea and coffee are also reasonable options. Some research, including meta-analyses reviewed by the British Liver Trust, suggests that moderate coffee consumption may have a protective effect on the liver, though the evidence is observational and coffee should not be consumed in excess for this reason alone.

Diet fizzy drinks are a lower-sugar alternative, but plain or sparkling water with a slice of lemon or cucumber is a more nutritionally neutral option. Reducing sugary drink intake gradually, rather than all at once, can make the change more sustainable for most people.

What does NHS guidance say about diet and fatty liver disease?

NHS and NICE guidance recommends a balanced diet limiting free sugars to no more than 30 g per day, weight management and structured lifestyle change as the primary interventions for NAFLD/MASLD.

NHS guidance on NAFLD/MASLD emphasises that dietary change and weight management are the most effective interventions currently available. At the time of writing, there is no licensed medication specifically indicated for NAFLD/MASLD in the UK; anyone seeking up-to-date information on this should check the NHS website or speak to their GP, as the licensing landscape may change. The NHS recommends that people with fatty liver disease aim to eat a balanced diet in line with the Eatwell Guide, which prioritises vegetables, wholegrains, lean proteins and healthy fats, while limiting foods and drinks high in free sugars, saturated fat and salt.

In relation to sugary drinks, NHS advice aligns with broader UK dietary guidelines from the Office for Health Improvement and Disparities (OHID), which recommend that free sugars should make up no more than 5% of daily energy intake for adults. For most adults, this equates to no more than 30 g of free sugars per day, an amount that a single large sugary fizzy drink can exceed on its own.

NICE guidance on the management of NAFLD (NG49) recommends that clinicians advise patients to lose weight if they have a BMI above the healthy range, as even a 5 to 10% reduction in body weight can meaningfully reduce liver fat. NICE also recommends that people with NAFLD/MASLD are assessed for cardiovascular risk, as the two conditions frequently coexist.^[9][10] The NICE pathway includes non-invasive fibrosis assessment using FIB-4 and, where indicated, ELF testing, with referral to secondary care for those with evidence of advanced fibrosis. People with NAFLD/MASLD are encouraged to engage with structured lifestyle programmes where available, and their GP can refer them to dietetic support or a liver specialist if the condition is more advanced.

Bolt Pharmacy is a GPhC-registered UK online pharmacy. For people managing metabolic risk factors alongside dietary change, an online weight-management consultation with Bolt may be one option to explore, with any prescription issued only where a prescriber considers it clinically appropriate following a full consultation.

Lifestyle changes that can help reverse early fatty liver disease

Losing 7 to 10% of body weight, following a Mediterranean-style diet, replacing sugary drinks with water, and achieving 150 minutes of moderate aerobic activity weekly can meaningfully reverse early fatty liver disease.

Early fatty liver disease can be reversed through sustained lifestyle changes, and the liver's capacity for regeneration means that meaningful improvement is achievable for many people. The most evidence-based interventions are weight loss, dietary modification and increased physical activity.

Weight loss is the single most effective intervention. NICE guidance (NG49) indicates that losing 7 to 10% of body weight can significantly reduce liver fat and inflammation. Even a 3 to 5% reduction can lower liver fat measurably. Gradual, sustained weight loss of 0.5 to 1 kg per week is preferable to rapid or crash dieting, which carries risks including gallstone formation and may not support sustained liver recovery.

Dietary changes that support liver recovery include:

• Replacing sugary drinks with water, unsweetened tea or coffee

• Reducing intake of ultra-processed foods, refined carbohydrates and foods high in saturated fat

• Increasing fibre intake through vegetables, legumes and wholegrains

• Following a Mediterranean-style eating pattern, which has specific evidence for reducing liver fat and is consistent with NICE NG49 recommendations^[18][19]

Physical activity improves insulin sensitivity and helps the liver process fat more efficiently. UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, such as brisk walking, cycling or swimming, alongside muscle-strengthening activities on two or more days per week.^[13][14] Both aerobic and resistance exercise have been shown in research to reduce liver fat independently of weight loss.^[21][22]

Alcohol reduction is also important, even for people with NAFLD/MASLD rather than alcoholic liver disease, as alcohol adds to the liver's workload. The UK Chief Medical Officers' low-risk drinking guidelines recommend keeping alcohol intake to no more than 14 units per week, spread across at least three days, with several alcohol-free days each week.^[15][16]

Regular monitoring by a GP is advisable for anyone with confirmed NAFLD/MASLD, to track liver enzyme levels and assess whether the condition is improving or progressing.

Scientific References

1. Quality standards for the management of non-alcoholic fatty liver disease (McPherson S et al., British Liver Trust).
2. Liver disease: applying All Our Health.
3. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
4. Sugar: the facts.
5. The Eatwell Guide.
6. SACN statement on the WHO guideline on non-sugar sweeteners.
7. Joint position statement on the use of low or no calorie sweeteners (LNCS).
8. The truth about sweeteners.
9. Metabolic dysfunction-associated steatotic liver disease (NG49).
10. Non-alcoholic fatty liver disease (NG49) – short version of draft guideline.
11. HTG655 final scope – NAFLD fibrosis assessment pathway (FIB-4, ELF, transient elastography).
12. National Diet and Nutrition Survey 2019 to 2023: report.
13. UK Chief Medical Officers' physical activity guidelines.
14. Physical activity guidelines for adults aged 19 to 64.
15. Alcohol consumption: advice on low risk drinking (UK Chief Medical Officers).
16. Delivering Better Oral Health – Chapter 12: alcohol.
17. Non-alcoholic fatty liver disease (NAFLD).
18. The impact of dietary interventions on liver health biomarkers in individuals with MASLD: a systematic literature review and meta-analysis of RCTs.
19. Comparative efficacy of different diet modalities on metabolic profiles and liver functions in MAFLD: a network meta-analysis.
20. A systematic review and meta-analysis of RCTs: effects of Mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD.
21. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independently of body weight (Hallsworth K et al.).
22. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Frequently Asked Questions